GLOW 70mg Blend
- ≥99% purity by HPLC
- Janoshik COA with every lot
- Lot-traceable from synthesis
- EU-synthesised
Specifications
Third Party Lab Tested
Every lot is independently HPLC-tested by Janoshik Analytical, Europe's reference laboratory for peptide purity assessment. The COA shipped with your order is theirs, not ours.
Storage & Handling
Lyophilized peptides should be stored below 16°C, protected from light and moisture, for up to 24 months. Once reconstituted, refrigerate and use within 30 days for protocol consistency.
Reconstitution
Reconstitute with bacteriostatic water using the volumes below. Add solvent slowly along the inside wall of the vial. Swirl gently, never shake, until fully dissolved.
Lab-handling protocol BAC Water · 0.9% benzyl alcohol The reconstitution solvent referenced above. Add to order →Three peptides. One defined research blend.
GLOW is a 70 MG research blend containing GHK-Cu 50 MG, BPC-157 10 MG and TB-500 10 MG. The formulation combines a copper-binding tripeptide with two peptide entities studied in extracellular-matrix, cell-migration and tissue-model research. Its component profile distinguishes GLOW from the two-compound WOLVERINE blend. GLOW is supplied as a lyophilized research vial within the NZM-Labs peptide collection.
Independent analytical testing establishes lot-specific HPLC purity and mass-spectrometry identity, with documentation available for each production batch. For laboratory research only.
| Compound 1 | GHK-Cu · 50 MG |
|---|---|
| Compound 2 | BPC-157 · 10 MG |
| Compound 3 | TB-500 · 10 MG |
| Mechanism / research class | Three-compound research-peptide blend |
| Example laboratory preparation | 70 MG blend vial with 3 mL bacteriostatic water (0.9% benzyl alcohol) |
| Calculated concentration | GHK-Cu 16.7 mg, BPC-157 3.3 mg and TB-500 3.3 mg per 1.0 mL |
| Supply format | GLOW · 70 MG blend lyophilized research vial |
| Storage, lyophilized | store below 16°C for up to 24 months |
| Storage, reconstituted | refrigerate and use within 30 days |
Synthesised.
Verified.
Documented.
Backed by research.
Measured in results.
Each tag opens the cited literature behind that effect. References are linked to PubMed.
GHK-Cu's copper-mediated mechanism upregulates collagen and elastin synthesis in dermal fibroblast models. Combined with BPC-157's structural-repair profile and TB-500's migration / angiogenesis activity, GLOW addresses dermal repair as a system rather than a single mechanism.
- Pickart L et al. GHK-Cu peptide and skin remodeling. BioMed Res Int. 2015;2015:648108. PubMed ↗
Each component covers a distinct mechanism in dermal-repair research: GHK-Cu (matrix remodeling), BPC-157 (structural protection), TB-500 (migration / angiogenesis). The 50/10/10 ratio is the most-replicable starting point in combined-mechanism dermal protocols.
- Pickart L et al. GHK in tissue regeneration. Chem Biol Drug Des. 2012;79(1):3-12. PubMed ↗
The bound Cu²⁺ ion in GHK-Cu participates in cellular redox cycles, producing measurable antioxidant activity in dermal models - distinct from the bare GHK tripeptide which lacks this mechanism.
- Beretta G et al. Antioxidant properties of GHK-Cu. Mol Cell Biochem. 2007;305(1-2):261-269. PubMed ↗
Questions?
We have answers.
No reviews yet
Write a review
Share your experience with GLOW 70mg Blend. Reviews are published after a manual check.